The National Institute for Health and Care Excellence (NICE) has recommended that a weekly injection of semaglutide is given to more than a million people to help prevent heart attacks and strokes. This latest recommendation is underpinned by several years of research supported by the NIHR. 

In March, Leicester Diabetes Centre (LDC)’s Professor Samuel Seidu visited Korle Bu Teaching Hospital in Ghana for a key project meeting for the CREATE study.